establishment of PCR assays. A total of 75 clinical and environmental A. fumigatus isolates were used for the evaluation of the developed methods. The background information regarding country of origin, source of isolation, susceptibility to itraconazole (including MICs), and presence or absence of TR 34 /L98H mutations in the cyp51A gene of A. fumigatus isolates tested for the performance of the molecular assays is presented in Table 1 . The details of clinical/environmental A. fumigatus isolates from France, The Netherlands, and India that were used in this study have also been published previously (4, 14, 15) . Drug susceptibility testing (DST) of A. fumigatus isolates with itraconazole was carried out by Etest as described elsewhere (16) . Isolates with reduced susceptibility to itraconazole (MIC of Ն2 g/ml) were also tested for voriconazole by a broth microdilution (M38-A2) method (4) . Isolates with MICs of Ն2 g/ml were considered resistant (4) .
DNA from the isolates was prepared and the internal transcribed spacer (ITS) region of ribosomal DNA (rDNA) was amplified with AFUF2 and AFUR2 primers for the identification of A. fumigatus isolates as described previously (17) . The presence or absence of TR 34 in the promoter region was determined by PCR amplification by using AFCYPPF (5=-AATAATCGCAGCACCAC TTC-3=) and AFCYPPR (5=-TGGTATGCTGGAACTACACCTT-3=) primers. PCR was carried out in a total volume of 50 l containing 1ϫ AmpliTaq PCR buffer I, 1 U AmpliTaq DNA polymerase, 4 pmol (each) of AFCYPPF and AFCYPPR primers, 2 l of DNA, and 0.1 mM each deoxynucleoside triphosphate (dNTP). PCR cycling (total, 35 cycles) included denaturation at 95°C for 1 min, annealing at 60°C for 30 s, and extension at 72°C for 1 min. An initial denaturation step at 95°C for 5 min and a final extension step at 72°C for 10 min were also included, and the amplicons were detected by use of 2% agarose gels (16) . A. fumigatus isolates containing TR 34 in the cyp51A promoter region should yield an amplicon of 139 bp, while isolates containing the wildtype sequence (no tandem repeat) should yield an amplicon of 105 bp. For the detection of the wild-type sequence or the L98H mutation at cyp51A98 in A. fumigatus isolates, DNA was amplified by using AFCYP98F (5=-CAAGTTCTTCTTTGCGTGCAGA-3=) and AFCYP98R (5=-ATAAGTGGCACATGAGACTCT-3=) primers and the reaction and cycling conditions described above. A portion (5 l) of PCR products was run on 2% agarose gels. Amplicons in the remaining sample (45 l) were purified with a PCR product purification kit (Qiagen) according to instructions supplied with the kit. Purified DNA (5 l) was digested with 5 units of AluI (New England Bio-Labs) in a final volume of 25 l at 37°C for 5 h, and digested products were separated by 2% agarose gels to generate PCR-restriction fragment length polymorphism (PCR-RFLP) patterns. The 350-bp amplicon from A. fumigatus isolates containing the wild-type (L98) sequence (CTC, encoding Leu) in cyp51A98 should yield three DNA fragments of 189 bp, 90 bp, and 71 bp (with the 189-bp fragment serving as the diagnostic fragment), while isolates containing the L98H mutation (CAC, encoding His) in cyp51A98 should yield two DNA fragments of 279 bp and 71 bp (with the 279-bp fragment serving as the diagnostic fragment). PCR amplicons from all A. fumigatus isolates were also sequenced to confirm the results. Sequencing reactions were carried out and data were analyzed as described previously (16) . In agarose gels, PCR amplification of the promoter region yielded distinct 105-bp and 139-bp amplicons from reference A. fumigatus isolates CBS 113.26 (containing the wild-type sequence) and VPCI1042/09 (containing TR 34 in the promoter region), respectively. Similarly, PCR-RFLP assay of reference A. fumigatus isolates CBS 113.26 (containing the wild-type sequence) and VPCI1042/09 (containing the L98H mutation at cyp51A98) yielded three (189-bp, 90-bp, and 71-bp) and two (279-bp and 71-bp) DNA fragments, respectively, as expected. Etest data showed that 40 A. fumigatus isolates were susceptible to itraconazole, while the remaining 35 isolates were resistant. All itraconazole-resistant isolates were also resistant to voriconazole according to the broth microdilution assay.
PCR amplification of the cyp51A98 region from all 40 itraconazole-susceptible and 35 itraconazole-resistant A. fumigatus isolates yielded an amplicon of ϳ350 bp (data from 7 isolates are shown in Fig. 1a) . When the amplicons were digested with AluI, 32 itraconazole-resistant isolates yielded two (279-bp and 71-bp) fragments (data from 8 isolates are shown in Fig. 1b, lanes 1 to 8) , indicating the L98H mutation, while 3 isolates yielded a wild-type pattern in cyp51A98. The latter 3 isolates contained a mutation at either codon 54 (two isolates) or codon 220 (one isolate) ( Table  1 ). The PCR-RFLP assay with all 40 itraconazole-susceptible isolates yielded three (189-bp, 90-bp, and 71-bp) fragments (data from 6 isolates are shown in Fig. 1b, lanes 9 to 14) indicating the wild-type sequence in cyp51A98. All 32 itraconazole-resistant isolates with the L98H mutation in cyp51A98 also yielded a 139-bp amplicon (data from 4 isolates are shown in Fig. 2, lanes 1, 2, 5 , and 6) for the promoter region, indicating the presence of TR 34 , while the remaining 3 itraconazole-resistant isolates and all 40 itraconazole-susceptible isolates yielded 105-bp amplicons (data from 4 isolates are shown in Fig. 2, lanes 3, 4, 7, and 8) , indicating the absence of the tandem-repeat sequence in the promoter region. The DNA sequencing data confirmed the results of PCR/ PCR-RFLP assays for all the isolates analyzed in this study. None of the A. fumigatus isolates lacking TR 34 /L98H mutations yielded false-positive results by PCR/PCR-RFLP assays. It is important to emphasize here that the PCR-RFLP assay described in this study is designed for the detection of only the L98H mutation within the cyp51A gene. Since other cyp51A mutations are known to occur in triazole-resistant A. fumigatus isolates, the lack of detection of the L98H mutation by the PCR-RFLP assay does not rule out triazole resistance (4, 6, 18) . Thus, there is a possibility of some triazoleresistant A. fumigatus isolates yielding false-negative results by exhibiting wild-type patterns for the promoter region and codon 98 of the cyp51A gene. Previously, the L98H mutation has been detected by other rapid molecular techniques, such as two (L98-specific and L98H-specific) PCR assays (10), PCR amplification of the cyp51A98 region followed by DNA sequencing (6, 13, 18) , real-time PCR with molecular beacons (12) , and melting-curve analysis of specific probe primers with real-time PCR amplicons (11) . TR 34 has also been detected by a PCR or nested PCR assay followed by DNA sequencing (6, 13, 18) , real-time PCR with molecular beacons (12) , and melting-curve analysis of PCR amplicons (11) . Most of these methods either are technically demanding or require expensive and sophisticated instruments/probes. A simple PCR-agarose gel assay similar to our protocol has been described previously (10) ; it generated amplicons of 188 bp and 222 bp from A. fumigatus isolates containing wild-type and TR 34 sequences in the promoter region, respectively. However, the amplicons of 105 bp and 139 bp obtained in this study resolve better in 2% agarose gels than the amplicons of 222 bp and 188 bp, since the distance traveled by a DNA fragment in agarose gels is inversely proportional to the log of its molecular weight (19) .
The PCR-based methods developed in this study for rapid identification of TR 34 /L98H mutations are simple to perform, use basic PCR and gel electrophoresis equipment that is readily available in most mycology laboratories, can be completed within 1 to 2 days, and cost ϳUS$5 per sample (excluding the cost of culture and personnel time). The methods will help in determining the prevalence of TR 34 /L98H mutations in the cyp51A gene in clinical and environmental A. fumigatus isolates in resource-poor settings. The application of these methods will also help in identifying another mechanism (TR 46 /Y121F/T289A mutations) conferring resistance to triazoles in clinical and environmental A. fumigatus isolates described recently (20) . This is because the L98H mutation without the TR 34 mutation has not been described previously. Thus, the detection of A. fumigatus isolates containing a tandem repeat in the promoter region but lacking the L98H mutation would indicate the presence of Y121F/T289A in the cyp51A gene, which could be subsequently confirmed by other methods (20) . Furthermore, the simple molecular assays developed in this study may also help in the rapid identification of TR 34 /L98H mutations in the cyp51A gene among clinical A. fumigatus isolates for proper management of patients with IA in developing countries. However, it should be emphasized here that the simple molecular assays described in this study are designed only for the detection of TR 34 /L98H mutations, and triazole-resistant A. fumigatus isolates harboring other mutations in the cyp51A gene will yield falsenegative results. 1, 2, 5 , and 6 indicates the presence of TR 34 , while the amplicon of ϳ105 bp in lanes 3, 4, 7, and 8 indicates the absence of TR 34 (wild-type sequence) in the promoter region of cyp51A. Lane M is a 100-bp DNA ladder, and the positions of migration of 100-bp, 300-bp, and 600-bp fragments are marked.
